-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS, INC. : BMO INITIATES COVERAGE WITH OUTPERFORM RATING; PRICE TARGET $318

Reuters·08/19/2026 10:45:40

Please log in to view news